Cargando…
Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics
Glioblastoma multiforme is the most aggressive malignant tumor of the central nervous system. Due to the absence of effective pharmacological and surgical treatments, the identification of early diagnostic and prognostic biomarkers is of key importance to improve the survival rate of patients and to...
Autores principales: | Silantyev, Artemiy S., Falzone, Luca, Libra, Massimo, Gurina, Olga I., Kardashova, Karina Sh., Nikolouzakis, Taxiarchis K., Nosyrev, Alexander E., Sutton, Christopher W., Mitsias, Panayiotis D., Tsatsakis, Aristides |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721640/ https://www.ncbi.nlm.nih.gov/pubmed/31405017 http://dx.doi.org/10.3390/cells8080863 |
Ejemplares similares
-
Proteomic dataset: Profiling of glioma C6 and astrocytes rat cell lines before and after co-cultivation
por: Silantyev, Artemiy S., et al.
Publicado: (2021) -
Dethroning the crown. From the kinetics and dynamics of COVID–19 diagnosis to promising treatments
por: Nikolouzakis, Taxiarchis Konstantinos, et al.
Publicado: (2021) -
Current and Future Trends in Molecular Biomarkers for Diagnostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin Cancer
por: Nikolouzakis, Taxiarchis Konstantinos, et al.
Publicado: (2020) -
Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients
por: Nikolouzakis, Taxiarchis Konstantinos, et al.
Publicado: (2018) -
Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements
por: Tuaeva, Natalia O., et al.
Publicado: (2019)